Last updated on 04 July 2025
As part of the clinical research it promotes, the ANRS MIE relies on several Methodology and Management Centres (MMG) to ensure the operational coordination of the studies, as well as on a network of hospital departments responsible for the inclusion and follow-up of participants. Clinical platforms such as OPEN-ReMIE, I-REIVAC Emergence and the Strive network are concrete examples of structures supported by the MMG network.
The mission of the MMGs is to support clinical research projects from their conception through to the exploitation of the results. This support includes drafting protocols, discussing study designs and assessing feasibility, thanks to their expertise in methodology, ethics and regulations. Project management continues at a practical and operational level, in coordination with the clinical research associates (CRAs) and data managers, particularly for data management (data protection, database management and cleaning, data analysis and exploitation of results).
Some of the agency’s MMGs receive multi-annual cross-funding for some of their staff (CRAs, project managers, quality specialists, statisticians, etc.) under the ‘Clinical Research Networks’ structuring action, which contributes to the organisation of the ANRS MIE clinical research network.
The centres also benefit from common tools (electronic CRF or e-CRF) and support in terms of quality assurance and pharmacovigilance.
The annual network meetings enable us to meet the teams behind the MMGs, with whom we collaborate within the network or through various research projects, such as the Strive network in our case. Even if all the information presented at these meetings is not necessarily useful to us, it gives us a direction to follow, to which we can add our own specific features. It also allows us to think about how to deepen our collaborations.
The members of the MMG network meet several times a year to discuss their experiences, share their skills and harmonise their practices. These exchanges take place in a variety of complementary formats:
The objectives of the MMG network are to harmonise practices, and to strengthen the skills of certain centres by drawing on the expertise of other network members in order to facilitate a rapid response and efficient implementation of studies in the event of an epidemic.
These working groups supported by the MMG network enable us to get to know each other and compare our activities and procedures. Eventually, we will be able to set up joint cross-disciplinary projects, structuring or sharing skills and knowledge. The advantage of having the ANRS MIE as a common promoter will enable stronger actions to be put in place, because they will be carried and supported by the ANRS MIE.
One concrete example is the launch of the ‘Decarbonisation of research’ working group. Its aim is to identify the MMG activities that have the greatest impact on the carbon footprint of clinical trials, in order to find ways of decarbonising the activity. These changes could then be implemented across all CMGs, for example at the request of ANRS MIE as sponsor.
The launch of the I-REIVAC-Emergence platform is a decisive step forward for French clinical research in vaccinology against emerging infectious diseases.
06 May 2025